Jporgan Chase将红衣主教健康公司的价格目标提高到123美元,并重申中立评级。 JPMorgan Chase raises Cardinal Health's price target to $123 and reaffirms neutral rating.

摩根大通将卡迪纳尔健康的目标价格从111.00美元提高到123.00美元, 保持中立评级. JPMorgan Chase & Co. raised Cardinal Health's (NYSE: CAH) price target from $111.00 to $123.00, maintaining a neutral rating. 分析师一致建议"适度购买", 平均12个月的目标价格为118.45美元. Analysts' consensus recommendation is "Moderate Buy" with an average 12-month price target of $118.45. 卡迪纳尔医疗报告了1.84美元的EPS,超过分析师估计的0.10美元,收入为59870亿美元. Cardinal Health reported $1.84 EPS, beating analyst estimates by $0.10 and had revenue of $59.87 billion. 该公司每季度支付每股0.506美元的股利,股利收益为1.85%。 The company pays a quarterly dividend of $0.506 per share, with a dividend yield of 1.85%.